Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,238.00    -18.00 (-1.43%)
Bid:
1,238.00
Ask:
1,242.00
Spread: 4.00 (0.323%)
Market Cap: £567.33m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

13 Aug 2015 07:00

RNS Number : 9010V
Cohort PLC
13 August 2015
 



13 August 2015

Cohort plc

("Cohort" or "the Group")

 

Cohort's MCL subsidiary wins MOD hearing protection contract

 

Cohort, the independent technology group, is pleased to announce that its subsidiary Marlborough Communications Ltd. (MCL) has been awarded a contract by the UK Ministry of Defence to provide the armed forces with tactical hearing protection systems for the dismounted close combat user ("THPS DCCU"). The award follows a competitive tender process.

 

The initial order value is £11.2m. Further orders are expected over the duration of the contract and the delivery schedule and total contract value are still the subject of discussion with the customer. The contract has been awarded for four years, with an option to extend it for a further three years.

 

The solution being supplied by MCL was developed in partnership with INVISIO Communications, a leading Danish audio technology company.

 

This contract win follows on from MCL's previous UK MOD win earlier in the year, supplying its Tactical In-Ear Protection Plugs as part of the tactical hearing protection system for the basic user soldier.

 

Andrew Thomis, Chief Executive of Cohort plc, said:

"We are delighted that MCL has been awarded the THPS DCCU contract. We look forward to working with the UK MOD to deliver this important equipment to soldiers.

"The contract will add significantly to our already strong order book, which substantially underpins our revenues for Cohort's current financial year."

 

ENDS

 

 

For further information please contact:

Cohort plc

Andy Thomis, Chief Executive

Simon Walther, Finance Director

 

0118 909 0390

Investec Bank plc

Keith Anderson / Daniel Adams

020 7597 5970

MHP Communications Limited

Reg Hoare / Jamie Ricketts

020 3128 8100

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company for four innovative, agile and responsive businesses working primarily for defence, wider government and industry clients.

 

· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006.

· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007.

 

· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 650 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey and Scotland.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTPKBDKABKDQFD
Date   Source Headline
5th Dec 20237:00 amRNSContract Win
1st Dec 20239:55 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSNotice of Half Year Results
6th Nov 202310:21 amRNSHolding(s) in Company
3rd Nov 202310:35 amRNSHolding(s) in Company
1st Nov 202310:03 amRNSTotal Voting Rights
19th Oct 20237:00 amRNSSHARES/AJ BELL IN-PERSON INVESTOR EVENT NEXT WEEK
16th Oct 20237:00 amRNSShares/AJ Bell Live Investor Event, October 25
13th Oct 20234:03 pmRNSDirector/PDMR Shareholding
6th Oct 20233:48 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:09 pmRNSBlock listing six monthly return
2nd Oct 20231:04 pmRNSTotal Voting Rights
29th Sep 202310:18 amRNSDirector/PDMR Shareholding
26th Sep 20235:00 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Statement & First Quarter Update
21st Sep 20233:45 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSTotal Voting Rights
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.